148 related articles for article (PubMed ID: 11449877)
1. Nateglinide.
Halas CJ
Am J Health Syst Pharm; 2001 Jul; 58(13):1200-5. PubMed ID: 11449877
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
McLeod JF
Clin Pharmacokinet; 2004; 43(2):97-120. PubMed ID: 14748619
[TBL] [Abstract][Full Text] [Related]
3. Nateglinide therapy for type 2 diabetes mellitus.
Levien TL; Baker DE; Campbell RK; White JR
Ann Pharmacother; 2001 Nov; 35(11):1426-34. PubMed ID: 11724096
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.
Keilson L; Mather S; Walter YH; Subramanian S; McLeod JF
J Clin Endocrinol Metab; 2000 Mar; 85(3):1081-6. PubMed ID: 10720043
[TBL] [Abstract][Full Text] [Related]
5. [Nateglinide].
Notoya Y; Kikuchi M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():371-5. PubMed ID: 12387020
[No Abstract] [Full Text] [Related]
6. Nateglinide (Starlix): update on a new antidiabetic agent.
Phillips LS; Dunning BE
Int J Clin Pract; 2003; 57(6):535-41. PubMed ID: 12918894
[TBL] [Abstract][Full Text] [Related]
7. Senaglinide. A 4166, AY 4166, Fastic, SDZ DJN 608, Starlix, Starsis, YM 026, Nateglinide.
Drugs R D; 1999 Aug; 2(2):123-6. PubMed ID: 10820657
[No Abstract] [Full Text] [Related]
8. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
Kikuchi M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S151-5. PubMed ID: 8894500
[TBL] [Abstract][Full Text] [Related]
9. Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.
Hirschberg Y; Karara AH; Pietri AO; McLeod JF
Diabetes Care; 2000 Mar; 23(3):349-53. PubMed ID: 10868864
[TBL] [Abstract][Full Text] [Related]
10. Meglitinide analogues in the treatment of type 2 diabetes mellitus.
Landgraf R
Drugs Aging; 2000 Nov; 17(5):411-25. PubMed ID: 11190420
[TBL] [Abstract][Full Text] [Related]
11. Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.
Pratley RE; Foley JE; Dunning BE
Curr Pharm Des; 2001 Sep; 7(14):1375-97. PubMed ID: 11472274
[TBL] [Abstract][Full Text] [Related]
12. Nateglinide.
Dunn CJ; Faulds D
Drugs; 2000 Sep; 60(3):607-615; discussion 616-7. PubMed ID: 11030470
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes].
Li YX; Ding GX; Li QF; Chen L; Hu GL; Ji QH; Wang SJ; Guo Y; Luo R; Hou WK; Wang PN; Zhang NY; Zhang YP; Wang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):211-3. PubMed ID: 18505128
[TBL] [Abstract][Full Text] [Related]
14. The effect of nateglinide taken with food on gastric emptying rates in healthy subjects.
Anderson D; Shelley S; Kellett N; Marshall D; Nimmo W
Clin Ther; 2003 Jun; 25(6):1722-38. PubMed ID: 12860494
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes.
Israel MK; Istvan E; Baron MA
Vasc Health Risk Manag; 2008; 4(6):1167-78. PubMed ID: 19337530
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.
Fonseca VA; Kelley DE; Cefalu W; Baron MA; Purkayastha D; Nestler JE; Hsia S; Gerich JE
Metabolism; 2004 Oct; 53(10):1331-5. PubMed ID: 15375790
[TBL] [Abstract][Full Text] [Related]
17. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
Campbell IW
Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.
Saloranta C; Hershon K; Ball M; Dickinson S; Holmes D
J Clin Endocrinol Metab; 2002 Sep; 87(9):4171-6. PubMed ID: 12213867
[TBL] [Abstract][Full Text] [Related]
19. Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus.
Walter YH; Spratt DI; Garreffa S; McLeod JF
Eur J Clin Pharmacol; 2000 May; 56(2):129-33. PubMed ID: 10877006
[TBL] [Abstract][Full Text] [Related]
20. Restoring post-prandial insulin release in type 2 diabetes.
Andrews J
Hosp Med; 2002 Feb; 63(2):95-8. PubMed ID: 11902096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
